Announcement by Johnson & Johnson Innovation, April 29, 2022
Johnson & Johnson Innovation Names Awardees in the Immunology Innovations QuickFire Challenge: Precision Medicine in Immune-Mediated Disease
On April 29 – the International Day of Immunology – Johnson & Johnson Innovation, together with Janssen Research & Development, announced that Metadvice and three other companies were awardees of the Immunology Innovations QuickFire Challenge: Precision Medicine in Immune-Mediated Disease. The challenge invited innovators with potential solutions aiming to advance precision medicine approaches in immune-mediated disease to apply for a combination of rewards to help advance their science.